BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19799612)

  • 1. Susceptibility of human T-cell leukemia virus type I-infected cells to humanized anti-CD30 monoclonal antibodies in vitro and in vivo.
    Maeda N; Muta H; Oflazoglu E; Yoshikai Y
    Cancer Sci; 2010 Jan; 101(1):224-30. PubMed ID: 19799612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD30 Expression and Its Functions during the Disease Progression of Adult T-Cell Leukemia/Lymphoma.
    Nakashima M; Uchimaru K
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100.
    Watanabe T; Yamashita S; Ureshino H; Kamachi K; Kurahashi Y; Fukuda-Kurahashi Y; Yoshida N; Hattori N; Nakamura H; Sato A; Kawaguchi A; Sueoka-Aragane N; Kojima K; Okada S; Ushijima T; Kimura S; Sueoka E
    Blood; 2020 Aug; 136(7):871-884. PubMed ID: 32391874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-CD30 monoclonal antibody SGN-30 promotes growth arrest and DNA fragmentation in vitro and affects antitumor activity in models of Hodgkin's disease.
    Wahl AF; Klussman K; Thompson JD; Chen JH; Francisco LV; Risdon G; Chace DF; Siegall CB; Francisco JA
    Cancer Res; 2002 Jul; 62(13):3736-42. PubMed ID: 12097283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling via the anti-CD30 mAb SGN-30 sensitizes Hodgkin's disease cells to conventional chemotherapeutics.
    Cerveny CG; Law CL; McCormick RS; Lenox JS; Hamblett KJ; Westendorf LE; Yamane AK; Petroziello JM; Francisco JA; Wahl AF
    Leukemia; 2005 Sep; 19(9):1648-55. PubMed ID: 16049514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIK-333 inhibits growth of human T-cell leukemia virus type I-infected T-cell lines and adult T-cell leukemia cells in association with blockade of nuclear factor-kappaB signal pathway.
    Okudaira T; Tomita M; Uchihara JN; Matsuda T; Ishikawa C; Kawakami H; Masuda M; Tanaka Y; Ohshiro K; Takasu N; Mori N
    Mol Cancer Ther; 2006 Mar; 5(3):704-12. PubMed ID: 16546985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD30 Characterizes Polylobated Lymphocytes and Disease Progression in HTLV-1-Infected Individuals.
    Nakashima M; Yamochi T; Watanabe M; Uchimaru K; Utsunomiya A; Higashihara M; Watanabe T; Horie R
    Clin Cancer Res; 2018 Nov; 24(21):5445-5457. PubMed ID: 30068708
    [No Abstract]   [Full Text] [Related]  

  • 8. An animal model of adult T-cell leukemia: humanized mice with HTLV-1-specific immunity.
    Tezuka K; Xun R; Tei M; Ueno T; Tanaka M; Takenouchi N; Fujisawa J
    Blood; 2014 Jan; 123(3):346-55. PubMed ID: 24196073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell death induced by dorsomorphin in adult T-cell leukemia/lymphoma is AMPK-independent.
    Aikawa A; Kozako T; Uchida Y; Yoshimitsu M; Ishitsuka K; Ohsugi T; Honda SI
    FEBS J; 2020 Sep; 287(18):4005-4015. PubMed ID: 32027454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophages contribute to the antitumor activity of the anti-CD30 antibody SGN-30.
    Oflazoglu E; Stone IJ; Gordon KA; Grewal IS; van Rooijen N; Law CL; Gerber HP
    Blood; 2007 Dec; 110(13):4370-2. PubMed ID: 17909075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells.
    Tomita M; Kawakami H; Uchihara JN; Okudaira T; Masuda M; Takasu N; Matsuda T; Ohta T; Tanaka Y; Ohshiro K; Mori N
    Int J Cancer; 2006 Feb; 118(3):765-72. PubMed ID: 16106398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma.
    Borchmann P; Treml JF; Hansen H; Gottstein C; Schnell R; Staak O; Zhang HF; Davis T; Keler T; Diehl V; Graziano RF; Engert A
    Blood; 2003 Nov; 102(10):3737-42. PubMed ID: 12881320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features of adult T-cell leukemia with CD30 antigen expression.
    Ohtsuka E; Kikuchi H; Nasu M; Takita-Sonoda Y; Fujii H; Yokoyama S
    Leuk Lymphoma; 1994 Oct; 15(3-4):303-10. PubMed ID: 7866279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fucoidan extracted from Cladosiphon okamuranus Tokida induces apoptosis of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.
    Haneji K; Matsuda T; Tomita M; Kawakami H; Ohshiro K; Uchihara JN; Masuda M; Takasu N; Tanaka Y; Ohta T; Mori N
    Nutr Cancer; 2005; 52(2):189-201. PubMed ID: 16201850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of adult T-cell leukaemia/lymphoma: is the virus a target?
    Cook LB; Taylor GP
    Curr Opin Infect Dis; 2015 Dec; 28(6):583-8. PubMed ID: 26381999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA ANRIL Supports Proliferation of Adult T-Cell Leukemia Cells through Cooperation with EZH2.
    Song Z; Wu W; Chen M; Cheng W; Yu J; Fang J; Xu L; Yasunaga JI; Matsuoka M; Zhao T
    J Virol; 2018 Dec; 92(24):. PubMed ID: 30258009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modified version of galectin-9 suppresses cell growth and induces apoptosis of human T-cell leukemia virus type I-infected T-cell lines.
    Okudaira T; Hirashima M; Ishikawa C; Makishi S; Tomita M; Matsuda T; Kawakami H; Taira N; Ohshiro K; Masuda M; Takasu N; Mori N
    Int J Cancer; 2007 May; 120(10):2251-61. PubMed ID: 17278100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse Models for HTLV-1 Infection and Adult T Cell Leukemia.
    Nakajima S; Okuma K
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Soluble CD30 as a Possible Marker of Adult T-cell Leukemia in HTLV-1 Carriers: a Nested Case-Control Study.
    Takemoto S; Iwanaga M; Sagara Y; Watanabe T
    Asian Pac J Cancer Prev; 2015; 16(18):8253-8. PubMed ID: 26745069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.